Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Through a series of expert-led local lives, simulcasts, and an on-demand webcast, learn how treatment sequencing for patients with HER2-positive metastatic breast cancer can be optimized, especially for those in the community setting.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.